Transcriptional regulation of mammalian selenoprotein expression

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 11, 2009, Pages 1429-1440

  Stoytcheva, Zoia R ^a   Berry, Marla J ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Oxidative stress; Selenium; Selenoprotein; Transcription

Indexed keywords

GLUTATHIONE PEROXIDASE; IODOTHYRONINE DEIODINASE; MESSENGER RNA; OXIDOREDUCTASE; SELENOPROTEIN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; UNCLASSIFIED DRUG;

ADAPTATION; BIOINFORMATICS; COMPLEX FORMATION; COMPUTER ANALYSIS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE EXPRESSION REGULATION; HUMAN; LUNG EMPHYSEMA; MAMMAL; MOLECULAR BIOLOGY; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; REVIEW; SIGNAL TRANSDUCTION; TATA BOX; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; HUMANS; IODIDE PEROXIDASE; MAMMALS; PROMOTER REGIONS, GENETIC; SELENOPROTEINS; THIOREDOXIN-DISULFIDE REDUCTASE; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 72649088108     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.05.012     Document Type: Review

References (140)

1. Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387 (2006) 1329-1335
2. Merante F., Altamentova S.M., Mickle D.A., Weisel R.D., Thatcher B.J., Martin B.M., Marshall J.G., Tumiati L.C., Cowan D.B., and Li R.K. The characterization and purification of a human transcription factor modulating the glutathione peroxidase gene in response to oxygen tension. Mol Cell Biochem 229 (2002) 73-83
3. Borras C., Gambini J., Gomez-Cabrera M.C., Sastre J., Pallardo F.V., Mann G.E., and Vina J. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 4 (2005) 113-118
4. Tan M., Li S., Swaroop M., Guan K., Oberley L.W., and Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274 (1999) 12061-12066
5. Jen K.Y., and Cheung V.G. Identification of novel p53 target genes in ionizing radiation response. Cancer Res 65 (2005) 7666-7673
6. Krieg A.J., Hammond E.M., and Giaccia A.J. Functional analysis of p53 binding under differential stresses. Mol Cell Biol 26 (2006) 7030-7045
7. Koumenis C., Alarcon R., Hammond E., Sutphin P., Hoffman W., Murphy M., Derr J., Taya Y., Lowe S.W., Kastan M., and Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 21 (2001) 1297-1310
8. Hammond E.M., Mandell D.J., Salim A., Krieg A.J., Johnson T.M., Shirazi H.A., Attardi L.D., and Giaccia A.J. Genome-wide analysis of p53 under hypoxic conditions. Mol Cell Biol 26 (2006) 3492-3504
9. Banning A., and Brigelius-Flohe R. NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression. Antioxid Redox Signal 7 (2005) 889-899
10. Kluth D., Banning A., Paur I., Blomhoff R., and Brigelius-Flohe R. Modulation of pregnane X receptor- and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic Biol Med 42 (2007) 315-325
11. Scott E.W., Simon M.C., Anastasi J., and Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994) 1573-1577
12. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., and Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15 (1996) 5647-5658
13. Anderson K.L., Perkin H., Surh C.D., Venturini S., Maki R.A., and Torbett B.E. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol 164 (2000) 1855-1861
14. Throm S.L., and Klemsz M.J. PU.1 regulates glutathione peroxidase expression in neutrophils. J Leukoc Biol 74 (2003) 111-117
15. Goven D., Boutten A., Lecon-Malas V., Marchal-Somme J., Amara N., Crestani B., Fournier M., Leseche G., Soler P., Boczkowski J., and Bonay M. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax 63 (2008) 916-924
16. Singh A., Rangasamy T., Thimmulappa R.K., Lee H., Osburn W.O., Brigelius-Flohe R., Kensler T.W., Yamamoto M., and Biswal S. Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am J Respir Cell Mol Biol 35 (2006) 639-650
17. Kipp A., Banning A., and Brigelius-Flohe R. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin. Biol Chem 388 (2007) 1027-1033
18. Habeos I.G., Ziros P.G., Chartoumpekis D., Psyrogiannis A., Kyriazopoulou V., and Papavassiliou A.G. Simvastatin activates Keap1/Nrf2 signaling in rat liver. J Mol Med 86 (2008) 1279-1285
19. Yan W., and Chen X. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. J Biol Chem 281 (2006) 7856-7862
20. Chu F.F., Esworthy R.S., Lee L., and Wilczynski S. Retinoic acid induces Gpx2 gene expression in MCF-7 human breast cancer cells. J Nutr 129 (1999) 1846-1854
21. Ouyang X., DeWeese T.L., Nelson W.G., and Abate-Shen C. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res 65 (2005) 6773-6779
22. Comhair S.A., Bhathena P.R., Farver C., Thunnissen F.B., and Erzurum S.C. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J 15 (2001) 70-78
23. Bierl C., Voetsch B., Jin R.C., Handy D.E., and Loscalzo J. Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem 279 (2004) 26839-26845
24. Ufer C., Borchert A., and Kuhn H. Functional characterization of cis- and trans-regulatory elements involved in expression of phospholipid hydroperoxide glutathione peroxidase. Nucleic Acids Res 31 (2003) 4293-4303
25. Tramer F., Vetere A., Martinelli M., Paroni F., Marsich E., Boitani C., Sandri G., and Panfili E. cAMP-response element modulator-tau activates a distinct promoter element for the expression of the phospholipid hydroperoxide/sperm nucleus glutathione peroxidase gene. Biochem J 383 (2004) 179-185
26. Borchert A., Savaskan N.E., and Kuhn H. Regulation of expression of the phospholipid hydroperoxide/sperm nucleus glutathione peroxidase gene. Tissue-specific expression pattern and identification of functional cis- and trans-regulatory elements. J Biol Chem 278 (2003) 2571-2580
27. Hattori H., Imai H., Furuhama K., Sato O., and Nakagawa Y. Induction of phospholipid hydroperoxide glutathione peroxidase in human polymorphonuclear neutrophils and HL60 cells stimulated with TNF-alpha. Biochem Biophys Res Commun 337 (2005) 464-473
28. Hattori H., Imai H., Kirai N., Furuhama K., Sato O., Konishi K., and Nakagawa Y. Identification of a responsible promoter region and a key transcription factor, CCAAT/enhancer-binding protein epsilon, for up-regulation of PHGPx in HL60 cells stimulated with TNF alpha. Biochem J 408 (2007) 277-286
29. Jurado J., Prieto-Alamo M.J., Madrid-Risquez J., and Pueyo C. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J Biol Chem 278 (2003) 45546-45554
30. Rundlof A.K., Carlsten M., and Arner E.S. The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene. J Biol Chem 276 (2001) 30542-30551
31. Reichard J.F., Motz G.T., and Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res 35 (2007) 7074-7086
32. Sakurai A., Nishimoto M., Himeno S., Imura N., Tsujimoto M., Kunimoto M., and Hara S. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. J Cell Physiol 203 (2005) 529-537
33. Chen Z.H., Saito Y., Yoshida Y., Sekine A., Noguchi N., and Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 280 (2005) 41921-41927
34. Dammeyer P., Damdimopoulos A.E., Nordman T., Jimenez A., Miranda-Vizuete A., and Arner E.S. Induction of cell membrane protrusions by the N-terminal glutaredoxin domain of a rare splice variant of human thioredoxin reductase 1. J Biol Chem 283 (2008) 2814-2821
35. Rundlof A.K., Fernandes A.P., Selenius M., Babic M., Shariatgorji M., Nilsonne G., Ilag L.L., Dobra K., and Bjornstedt M. Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells. Differentiation 75 (2007) 123-132
36. Rundlof A.K., Janard M., Miranda-Vizuete A., and Arner E.S. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic Biol Med 36 (2004) 641-656
37. Damdimopoulos A.E., Miranda-Vizuete A., Treuter E., Gustafsson J.A., and Spyrou G. An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J Biol Chem 279 (2004) 38721-38729
38. Gasdaska J.R., Harney J.W., Gasdaska P.Y., Powis G., and Berry M.J. Regulation of human thioredoxin reductase expression and activity by 3'-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem 274 (1999) 25379-25385
39. Zhou J., Eleni C., Spyrou G., and Brune B. The mitochondrial thioredoxin system regulates nitric oxide-induced HIF-1alpha protein. Free Radic Biol Med 44 (2008) 91-98
40. Yonehara K., Suzuki M., Yamanouchi K., and Nishihara M. Expression analyses of sex steroid-regulated genes in neonatal rat hypothalamus. J Reprod Dev 49 (2003) 547-552
41. De Luca A., Sacchetta P., Nieddu M., Di Ilio C., and Favaloro B. Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter. BMC Mol Biol 8 (2007) 39
42. Bianco A.C., Salvatore D., Gereben B., Berry M.J., and Larsen P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23 (2002) 38-89
43. Ohguchi H., Tanaka T., Uchida A., Magoori K., Kudo H., Kim I., Daigo K., Sakakibara I., Okamura M., Harigae H., Sasaki T., Osborne T.F., Gonzalez F.J., Hamakubo T., Kodama T., and Sakai J. Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. Mol Cell Biol 28 (2008) 3917-3931
44. Toyoda N., Zavacki A.M., Maia A.L., Harney J.W., and Larsen P.R. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol Cell Biol 15 (1995) 5100-5112
45. Schreck R., Schnieders F., Schmutzler C., and Kohrle J. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. J Clin Endocrinol Metab 79 (1994) 791-798
46. Jakobs T.C., Schmutzler C., Meissner J., and Kohrle J. The promoter of the human type I 5'-deiodinase gene-mapping of the transcription start site and identification of a DR+4 thyroid-hormone-responsive element. Eur J Biochem 247 (1997) 288-297
47. Schmutzler C., and Kohrle J. Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid 10 (2000) 393-406
48. Zhang C.Y., Kim S., Harney J.W., and Larsen P.R. Further characterization of thyroid hormone response elements in the human type 1 iodothyronine deiodinase gene. Endocrinology 139 (1998) 1156-1163
49. Toyoda N., Nishikawa M., Mori Y., Gondou A., Ogawa Y., Yonemoto T., Yoshimura M., Masaki H., and Inada M. Thyrotropin and triiodothyronine regulate iodothyronine 5'-deiodinase messenger ribonucleic acid levels in FRTL-5 rat thyroid cells. Endocrinology 131 (1992) 389-394
50. Boelen A., Platvoet-Ter Schiphorst M.C., and Wiersinga W.M. Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 77 (1993) 1695-1699
51. Chopra I.J., Sakane S., and Teco G.N. A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab 72 (1991) 1113-1116
52. van der Poll T., Romijn J.A., Wiersinga W.M., and Sauerwein H.P. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71 (1990) 1567-1572
53. Pekary A.E., Berg L., Santini F., Chopra I., and Hershman J.M. Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol Cell Endocrinol 101 (1994) R31-R35
54. Gereben B., Salvatore D., Harney J.W., Tu H.M., and Larsen P.R. The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1). Mol Endocrinol 15 (2001) 112-124
55. Dentice M., Morisco C., Vitale M., Rossi G., Fenzi G., and Salvatore D. The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. Mol Endocrinol 17 (2003) 1508-1521
56. Zeold A., Doleschall M., Haffner M.C., Capelo L.P., Menyhert J., Liposits Z., da Silva W.S., Bianco A.C., Kacskovics I., Fekete C., and Gereben B. Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene. Endocrinology 147 (2006) 4419-4429
57. Bartha T., Kim S.W., Salvatore D., Gereben B., Tu H.M., Harney J.W., Rudas P., and Larsen P.R. Characterization of the 5'-flanking and 5'-untranslated regions of the cyclic adenosine 3',5'-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology 141 (2000) 229-237
58. Canettieri G., Franchi A., Sibilla R., Guzman E., and Centanni M. Functional characterisation of the CRE/TATA box unit of type 2 deiodinase gene promoter in a human choriocarcinoma cell line. J Mol Endocrinol 33 (2004) 51-58
59. Canettieri G., Franchi A., Guardia M.D., Morantte I., Santaguida M.G., Harney J.W., Larsen P.R., and Centanni M. Activation of thyroid hormone is transcriptionally regulated by epidermal growth factor in human placenta-derived JEG3 cells. Endocrinology 149 (2008) 695-702
60. Silva J.E., and Larsen P.R. Comparison of iodothyronine 5'-deiodinase and other thyroid-hormone-dependent enzyme activities in the cerebral cortex of hypothyroid neonatal rat. Evidence for adaptation to hypothyroidism. J Clin Invest 70 (1982) 1110-1123
61. St Germain D.L. Metabolic effect of 3,3',5'-triiodothyronine in cultured growth hormone-producing rat pituitary tumor cells. Evidence for a unique mechanism of thyroid hormone action. J Clin Invest 76 (1985) 890-893
62. St Germain D.L. The effects and interactions of substrates, inhibitors, and the cellular thiol-disulfide balance on the regulation of type II iodothyronine 5'-deiodinase. Endocrinology 122 (1988) 1860-1868
63. Croteau W., Davey J.C., Galton V.A., and St Germain D.L. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98 (1996) 405-417
64. Gereben B., Bartha T., Tu H.M., Harney J.W., Rudas P., and Larsen P.R. Cloning and expression of the chicken type 2 iodothyronine 5'-deiodinase. J Biol Chem 274 (1999) 13768-13776
65. Tu H.M., Kim S.W., Salvatore D., Bartha T., Legradi G., Larsen P.R., and Lechan R.M. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138 (1997) 3359-3368
66. Burmeister L.A., Pachucki J., and St Germain D.L. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138 (1997) 5231-5237
67. Leonard J.L., Kaplan M.M., Visser T.J., Silva J.E., and Larsen P.R. Cerebral cortex responds rapidly to thyroid hormones. Science 214 (1981) 571-573
68. Kim S.W., Harney J.W., and Larsen P.R. Studies of the hormonal regulation of type 2 5'-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 139 (1998) 4895-4905
69. Kamiya Y., Murakami M., Araki O., Hosoi Y., Ogiwara T., Mizuma H., and Mori M. Pretranslational regulation of rhythmic type II iodothyronine deiodinase expression by beta-adrenergic mechanism in the rat pineal gland. Endocrinology 140 (1999) 1272-1278
70. Tanaka K., Murakami M., and Greer M.A. Type-II thyroxine 5'-deiodinase is present in the rat pineal gland. Biochem Biophys Res Commun 137 (1986) 863-868
71. Guadano-Ferraz A., Escamez M.J., Rausell E., and Bernal J. Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J Neurosci 19 (1999) 3430-3439
72. Baumgartner A., Hiedra L., Pinna G., Eravci M., Prengel H., and Meinhold H. Rat brain type II 5'-iodothyronine deiodinase activity is extremely sensitive to stress. J Neurochem 71 (1998) 817-826
73. Zou L., Burmeister L.A., Styren S.D., Kochanek P.M., and DeKosky S.T. Up-regulation of type 2 iodothyronine deiodinase mRNA in reactive astrocytes following traumatic brain injury in the rat. J Neurochem 71 (1998) 887-890
74. Huang S.A., Mulcahey M.A., Crescenzi A., Chung M., Kim B.W., Barnes C., Kuijt W., Turano H., Harney J., and Larsen P.R. Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Mol Endocrinol 19 (2005) 3126-3136
75. Simonides W.S., Mulcahey M.A., Redout E.M., Muller A., Zuidwijk M.J., Visser T.J., Wassen F.W., Crescenzi A., da-Silva W.S., Harney J., Engel F.B., Obregon M.J., Larsen P.R., Bianco A.C., and Huang S.A. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 118 (2008) 975-983
76. Dentice M., Luongo C., Huang S., Ambrosio R., Elefante A., Mirebeau-Prunier D., Zavacki A.M., Fenzi G., Grachtchouk M., Hutchin M., Dlugosz A.A., Bianco A.C., Missero C., Larsen P.R., and Salvatore D. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci U S A 104 (2007) 14466-14471
77. Chen J.K., Taipale J., Cooper M.K., and Beachy P.A. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 16 (2002) 2743-2748
78. Wang G., Wang B., and Jiang J. Protein kinase A antagonizes Hedgehog signaling by regulating both the activator and repressor forms of Cubitus interruptus. Genes Dev 13 (1999) 2828-2837
79. Emerson C.H., Bambini G., Alex S., Castro M.I., Roti E., and Braverman L.E. The effect of thyroid dysfunction and fasting on placenta inner ring deiodinase activity in the rat. Endocrinology 122 (1988) 809-816
80. Roti E., Braverman L.E., Fang S.L., Alex S., and Emerson C.H. Ontogenesis of placental inner ring thyroxine deiodinase and amniotic fluid 3,3',5'-triiodothyronine concentration in the rat. Endocrinology 111 (1982) 959-963
81. Esfandiari A., Gagelin C., Gavaret J.M., Pavelka S., Lennon A.M., Pierre M., and Courtin F. Induction of type III-deiodinase activity in astroglial cells by retinoids. Glia 11 (1994) 255-261
82. Kester M.H., Kuiper G.G., Versteeg R., and Visser T.J. Regulation of type III iodothyronine deiodinase expression in human cell lines. Endocrinology 147 (2006) 5845-5854
83. Lamirand A., Pallud-Mothre S., Ramauge M., Pierre M., and Courtin F. Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes. Endocrinology 149 (2008) 3713-3721
84. Steinert P., Bachner D., and Flohe L. Analysis of the mouse selenoprotein P gene. Biol Chem 379 (1998) 683-691
85. Grigo K., Wirsing A., Lucas B., Klein-Hitpass L., and Ryffel G.U. HNF4 alpha orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells. Biol Chem 389 (2008) 179-187
86. Walter P.L., Steinbrenner H., Barthel A., and Klotz L.O. Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor. Biochem Biophys Res Commun 365 (2008) 316-321
87. Furukawa-Hibi Y., Kobayashi Y., Chen C., and Motoyama N. FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal 7 (2005) 752-760
88. Gao Y., Hannan N.R., Wanyonyi S., Konstantopolous N., Pagnon J., Feng H.C., Jowett J.B., Kim K.H., Walder K., and Collier G.R. Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 33 (2006) 246-251
89. Beilstein M.A., Vendeland S.C., Barofsky E., Jensen O.N., and Whanger P.D. Selenoprotein W of rat muscle binds glutathione and an unknown small molecular weight moiety. J Inorg Biochem 61 (1996) 117-124
90. Jeong D., Kim T.S., Chung Y.W., Lee B.J., and Kim I.Y. Selenoprotein W is a glutathione-dependent antioxidant in vivo. FEBS Lett 517 (2002) 225-228
91. Wimmer U., Wang Y., Georgiev O., and Schaffner W. Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucleic Acids Res 33 (2005) 5715-5727
92. Amantana A., Vorachek W.R., Butler J.A., Ream W., and Whanger P.D. Identification of putative transcription factor binding sites in rodent selenoprotein W promoter. J Inorg Biochem 98 (2004) 1513-1520
93. Amantana A., Vorachek W.R., Butler J.A., Costa N.D., and Whanger P.D. Effect of copper, zinc and cadmium on the promoter of selenoprotein W in glial and myoblast cells. J Inorg Biochem 91 (2002) 356-362
94. Aso T., Conaway J.W., and Conaway R.C. Role of core promoter structure in assembly of the RNA polymerase II preinitiation complex. A common pathway for formation of preinitiation intermediates at many TATA and TATA-less promoters. J Biol Chem 269 (1994) 26575-26583
95. Gross P., and Oelgeschlager T. Core promoter-selective RNA polymerase II transcription. Biochem Soc Symp (2006) 225-236
96. Arkhipova I.R. Promoter elements in Drosophila melanogaster revealed by sequence analysis. Genetics 139 (1995) 1359-1369
97. Dreher I., Jakobs T.C., and Kohrle J. Cloning and characterization of the human selenoprotein P promoter. Response of selenoprotein P expression to cytokines in liver cells. J Biol Chem 272 (1997) 29364-29371
98. Yasui Y., Hasada K., Yang J.G., and Koiwai O. Structure and organization of the gene encoding human selenoprotein. Gene 175 (1996) 269-270
99. Hernandez A., Lyon G.J., Schneider M.J., and St Germain D.L. Isolation and characterization of the mouse gene for the type 3 iodothyronine deiodinase. Endocrinology 140 (1999) 124-130
100. Bellingham J., Gregory-Evans K., Fox M.F., and Gregory-Evans C.Y. Gene structure and tissue expression of human selenoprotein W, SEPW1, and identification of a retroprocessed pseudogene, SEPW1P. Biochim Biophys Acta 1627 (2003) 140-146
101. Whanger P.D., Vendeland S.C., Gu Q.P., Beilstein M.A., and Ream L.W. Selenoprotein W cDNAs from five species of animals. Biomed Environ Sci 10 (1997) 190-197
102. Moreno S.G., Laux G., Brielmeier M., Bornkamm G.W., and Conrad M. Testis-specific expression of the nuclear form of phospholipid hydroperoxide glutathione peroxidase (PHGPx). Biol Chem 384 (2003) 635-643
103. Adham I.M., Tessmann D., Soliman K.A., Murphy D., Kremling H., Szpirer C., and Engel W. Cloning, expression, and chromosomal localization of the rat mitochondrial capsule selenoprotein gene (MCS): the reading frame does not contain potential UGA selenocysteine codons. DNA Cell Biol 15 (1996) 159-166
104. Hatfield M.B.D., and Gladyshev V. Selenium its Molecular Biology and Role in Human Health Springer Science+business Media (2006)
105. Orozco A., Jeziorski M.C., Linser P.J., Greenberg R.M., and Valverde R.C. Cloning of the gene and complete cDNA encoding a type 2 deiodinase from Fundulus heteroclitus. Gen Comp Endocrinol 128 (2002) 162-167
106. Azizkhan J.C., Jensen D.E., Pierce A.J., and Wade M. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit Rev Eukaryot Gene Expr 3 (1993) 229-254
107. Colgan J., and Manley J.L. Cooperation between core promoter elements influences transcriptional activity in vivo. Proc Natl Acad Sci U S A 92 (1995) 1955-1959
108. Pugh B.F., and Tjian R. Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell 61 (1990) 1187-1197
109. Wiley S.R., Kraus R.J., and Mertz J.E. Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters. Proc Natl Acad Sci U S A 89 (1992) 5814-5818
110. Jolliff K., Li Y., and Johnson L.F. Multiple protein-DNA interactions in the TATAA-less mouse thymidylate synthase promoter. Nucleic Acids Res 19 (1991) 2267-2274
111. Kollmar R., Sukow K.A., Sponagle S.K., and Farnham P.J. Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. J Biol Chem 269 (1994) 2252-2257
112. Lu J., Lee W., Jiang C., and Keller E.B. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J Biol Chem 269 (1994) 5391-5402
113. Boam D.S., Davidson I., and Chambon P. A TATA-less promoter containing binding sites for ubiquitous transcription factors mediates cell type-specific regulation of the gene for transcription enhancer factor-1 (TEF-1). J Biol Chem 270 (1995) 19487-19494
114. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72 (2003) 291-336
115. Kim E., Goren A., and Ast G. Alternative splicing: current perspectives. Bioessays 30 (2008) 38-47
116. Lopez A.J. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu Rev Genet 32 (1998) 279-305
117. Thierry-Mieg D., and Thierry-Mieg J. AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1 (2006) 11-14 S12
118. Ohba K., Yoshioka T., and Muraki T. Identification of two novel splicing variants of human type II iodothyronine deiodinase mRNA. Mol Cell Endocrinol 172 (2001) 169-175
119. Pfeifer H., Conrad M., Roethlein D., Kyriakopoulos A., Brielmeier M., Bornkamm G.W., and Behne D. Identification of a specific sperm nuclei selenoenzyme necessary for protamine thiol cross-linking during sperm maturation. FASEB J 15 (2001) 1236-1238
120. Puglisi R., Tramer F., Panfili E., Micali F., Sandri G., and Boitani C. Differential splicing of the phospholipid hydroperoxide glutathione peroxidase gene in diploid and haploid male germ cells in the rat. Biol Reprod 68 (2003) 405-411
121. Moghadaszadeh B., Petit N., Jaillard C., Brockington M., Roy S.Q., Merlini L., Romero N., Estournet B., Desguerre I., Chaigne D., Muntoni F., Topaloglu H., and Guicheney P. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 29 (2001) 17-18
122. Osborne S.A., and Tonissen K.F. Genomic organisation and alternative splicing of mouse and human thioredoxin reductase 1 genes. BMC Genomics 2 (2001) 10
123. Sun Q.A., Zappacosta F., Factor V.M., Wirth P.J., Hatfield D.L., and Gladyshev V.N. Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J Biol Chem 276 (2001) 3106-3114
124. Rundlof A.K., Carlsten M., Giacobini M.M., and Arner E.S. Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5' untranslated region. Biochem J 347 Pt 3 (2000) 661-668
125. Lescure A., Gautheret D., Carbon P., and Krol A. Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif. J Biol Chem 274 (1999) 38147-38154
126. Pushpa-Rekha T.R., Burdsall A.L., Oleksa L.M., Chisolm G.M., and Driscoll D.M. Rat phospholipid-hydroperoxide glutathione peroxidase. cDNA cloning and identification of multiple transcription and translation start sites. J Biol Chem 270 (1995) 26993-26999
127. Suske G. The Sp-family of transcription factors. Gene 238 (1999) 291-300
128. Dynan W.S., and Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35 (1983) 79-87
129. Hagen G., Muller S., Beato M., and Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13 (1994) 3843-3851
130. Hagen G., Dennig J., Preiss A., Beato M., and Suske G. Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. J Biol Chem 270 (1995) 24989-24994
131. Hagen G., Muller S., Beato M., and Suske G. Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res 20 (1992) 5519-5525
132. Hata Y., Duh E., Zhang K., Robinson G.S., and Aiello L.P. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem 273 (1998) 19294-19303
133. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., and Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72 (1998) 141-196
134. Bird A.P. Gene number, noise reduction and biological complexity. Trends Genet 11 (1995) 94-100
135. Singer-Sam J., and Riggs A.D. X chromosome inactivation and DNA methylation. EXS 64 (1993) 358-384
136. Tazi J., and Bird A. Alternative chromatin structure at CpG islands. Cell 60 (1990) 909-920
137. Kass S.U., Landsberger N., and Wolffe A.P. DNA methylation directs a time-dependent repression of transcription initiation. Curr Biol 7 (1997) 157-165
138. Comb M., and Goodman H.M. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 18 (1990) 3975-3982
139. Holler M., Westin G., Jiricny J., and Schaffner W. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 2 (1988) 1127-1135
140. Clark S.J., Harrison J., and Molloy P.L. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 195 (1997) 67-71